Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
05 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/05/3037749/0/en/Syndax-Pharmaceuticals-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html
25 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/25/3031829/0/en/Syndax-Announces-Participation-in-March-Investor-Conferences.html
24 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/24/3030998/0/en/Syndax-to-Announce-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Host-Conference-Call-and-Webcast-on-March-3-2025.html
04 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302367038.html
30 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/syndax-announces-participation-in-february-investor-conferences-302363686.html
15 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/incyte-and-syndax-announce-us-food-and-drug-administration-fda-approval-of-niktimvo-axatilimab-csfr-9-mg-and-22-mg-vial-sizes-302352411.html
ABOUT THIS PAGE